StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$12.75−0.40 (-3.04%)

Close on Nov 16, 2026Market cap $86.56MP/E –Yield –

Eloxx Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Eloxx Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2012 was -2533.1%. For fiscal 2024 it was -49.4%, against -5062.4% the year before. The highest annual figure on record is -49.4% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-49.4%+5013.0
FY2014Jun 30, 2014-5062.4%+73240.9
FY2013Jun 30, 2013-78303.4%−75770.3
FY2012Jun 30, 2012-2533.1%+7026.6
FY2010Jun 30, 2010-9559.7%–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?